Takeda to grow on acquisitions but challenges ahead
This article was originally published in Scrip
Executive Summary
As Takeda prepares to announce its fiscal year results on 9 May, recent news flow surrounding Asia's largest pharma company and some of its products - particularly in the US, its main market - has not been positive.